首站-论文投稿智能助手
典型文献
妊娠期抗精神病药的合理使用、不良反应及风险干预
文献摘要:
孕妇是精神疾病的高危人群.与精神分裂症相似,患有双相情感障碍的女性在产前和产后复发的风险也增加.当非药物治疗效果不理想,或当疾病风险大于胎儿接触药物的风险时,使用抗精神病药物控制病情尤为重要.然而,在怀孕期间进行药物治疗可能会对发育中的胎儿产生重大影响.早期研究表明,患有精神分裂症的孕妇其新生儿围产期畸形和死亡人数有所增加.抗精神病药物很容易穿过胎盘,怀孕期间接触抗精神病药物与潜在的致畸性有关.与孕妇使用抗精神病药相关的潜在风险包括先天性异常、早产和代谢紊乱,这可能导致胎儿发育异常.孕妇精神疾病的治疗方案必须评估抗精神病药物的风险和益处.本文综述了妊娠期抗精神病药的合理使用、不良反应及风险干预,有助于指导临床用药.
文献关键词:
抗精神病药;妊娠;精神病;并发症;致畸性
作者姓名:
常桂花;刘春文
作者机构:
临沂市精神卫生中心精神科,山东临沂 276005;青岛大学医学部精神与心理教研室,山东青岛 266000
引用格式:
[1]常桂花;刘春文-.妊娠期抗精神病药的合理使用、不良反应及风险干预)[J].中国药物滥用防治杂志,2022(11):1562-1567,1571
A类:
B类:
妊娠期,风险干预,孕妇,精神疾病,高危人群,精神分裂症,患有,双相情感障碍,产前,非药物治疗,药物治疗效果,疾病风险,抗精神病药物,药物控制,怀孕期,重大影响,早期研究,新生儿,围产期,死亡人数,穿过,胎盘,致畸性,潜在风险,先天性,早产,代谢紊乱,胎儿发育异常,益处,临床用药
AB值:
0.246463
相似文献
神经精神药理学治疗药物监测共识指南:2017版
C.Hiemke;N.Bergemann;H.W.Clement;A.Conca;J.Deckert;K.Domschke;G.Eckermann;K.Egberts;M.Gerlach;C.Greiner;G.Gründer;E.Haen;U.Havemann-Reinecke;G.Hefner;R.Helmer;G.Janssen;E-.Jaquenoud;G.Laux;T.Messer;R.M?ssner;M.J.Müller;M.Paulzen;B.Pfuhlmann;P.Riederer;A.Saria;B.Schoppek;G.Schoretsanitis;M.Schwarz;M.Silva Gracia;B.Stegmann;W.Steimer;J.C.Stingl;M.Uhr;S.Ulrich;S.Unterecker;R.Waschgler;G.Zernig;G.Zurek;P.Baumann;李文标;果伟;贺静;鲍爽;路钊;牛梦溪;阮灿军;臧彦楠;王勇;张玲;刘辰庚;李洁-Department of Psychiatry and Psychotherapy,University Medical Center of Mainz,Mainz,Germany;Institute of Clinical Chemistry and Laboratory Medicine,University Medical Center of Mainz,Mainz,Germany;Kitzberg Hospitals,Center for Psychosomatic Medicine and Psychotherapy,Bad Mergentheim,Germany;Department of Child and Adolescent Psychiatry,University of Freiburg,Freiburg,Germany;Servizio Psichiatrico del Comprensorio Sanitario di Bolzano,Bolzano,Italy;Department of Psychiatry,Psychotherapy and Psychosomatics,University Hospital of Würzburg,Germany;Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg,Freiburg,Germany;Psychiatric Hospital,Kaufbeuren,Germany;Department of Child and Adolescent Psychiatry,Psychosomatics and Psychotherapy,Center of Mental Health,University Hospi-tal of Würzburg,Germany;Federal Institute for Drugs and Medical Devices (BfArM),Bonn,Germany;Department of Psychiatry,Psychotherapy and Psychosomatics,RWTH Aachen University,Aachen,and JARA–Translational Brain Medicine,Aachen,Germany;Clinical Pharmacology,Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology,Uni-versity of Regensburg,Regensburg,Germany;Department of Psychiatry and Psychosomatics,University of G?ttingen,G?ttingen,Germany;Psychiatric Hospital,Vitos Klinik,Eichberg,Eltville,Germany;Center of Epilepsy,Bielefeld,Germany;Medical Laboratory Stein,Limbach Group,M?nchengladbach,Germany;Psychiatric Hospital,K?nigsfelden,Brugg,Aargau,Switzerland;Institute of Psychological Medicine,Haag in Oberbayern,Germany;Danuviuskliniken,Psychiatric Hospital,Pfaffenhofen,Germany;Department of Psychiatry and Psychotherapy,University of Tübingen,Tübingen,Germany;Psychiatric Hospitals Oberberggruppe,Berlin,Germany;Psychiatric Hospital Weisser Hirsch,Dresden,Germany;Experimental Psychiatry Unit,Department of Psychiatry1,Medical University of Innsbruck,Innsbruck,Austria;kbo-Isar-Amper Klinikum München-Ost,Psychiatric Hospital,Munich-Haar,Germany;Department of Psychiatry,University of Bern,Bern,Switzerland;Department of Laboratory Medicine,Ludwig Maximilian University,Munich,Germany;Institute of Clinical Chemistry and Pathobiochemistry,Technical University Munich,Munich,Germany;Max Planck Institute of Psychiatry,Munich,Germany;Aristo Pharma GmbH,Berlin,Germany;Psychiatric Hospital,Feldkirch,Austria;Private Practice for Psychotherapy and Court-Certified Witness,Hall in Tirol,Austria;Medical Laboratory Bremen,Bremen,Germany;Department of Psychiatry,University of Lausanne,Prilly-Lausanne,Switzerland;中国 北京 首都医科大学附属北京安定医院,国家精神心理疾病临床医学研究中心,精神疾病诊断与治疗北京重点实验室;中国 天津 天津市安定医院
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。